News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
459,189 Results
Type
Article (28344)
Company Profile (70)
Press Release (430774)
Multimedia
Podcasts (118)
Webinars (13)
Section
Business (138536)
Career Advice (1575)
Deals (20784)
Drug Delivery (71)
Drug Development (50741)
Employer Resources (102)
FDA (10718)
Job Trends (9979)
News (225072)
Policy (21056)
Tag
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (1863)
Academic (2)
Accelerated approval (18)
Adcomms (14)
Allergies (107)
Alliances (37975)
ALS (135)
Alzheimer's disease (1225)
Antibody-drug conjugate (ADC) (249)
Approvals (11026)
Artificial intelligence (449)
Autoimmune disease (125)
Automation (35)
Bankruptcy (182)
Best Places to Work (8109)
BIOSECURE Act (7)
Biosimilars (135)
Biotechnology (48)
Bladder cancer (138)
Brain cancer (44)
Breast cancer (528)
Cancer (3957)
Cardiovascular disease (317)
Career advice (1364)
Career pathing (30)
CAR-T (190)
CDC (24)
Celiac Disease (1)
Cell therapy (558)
Cervical cancer (33)
Clinical research (44079)
Collaboration (1531)
Company closure (3)
Compensation (594)
Complete response letters (29)
COVID-19 (1908)
CRISPR (79)
C-suite (632)
Cystic fibrosis (100)
Data (5229)
Decentralized trials (2)
Denatured (42)
Depression (93)
Diabetes (382)
Diagnostics (5427)
Digital health (39)
Diversity (7)
Diversity, equity & inclusion (30)
Drug discovery (228)
Drug pricing (105)
Drug shortages (22)
Duchenne muscular dystrophy (179)
Earnings (63944)
Editorial (45)
Employer branding (14)
Employer resources (88)
Events (68617)
Executive appointments (773)
FDA (13221)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (6)
Frontotemporal dementia (19)
Funding (1162)
Gene editing (161)
Generative AI (46)
Gene therapy (473)
GLP-1 (684)
Government (3068)
Grass and pollen (7)
Guidances (347)
Healthcare (11929)
HIV (51)
Huntington's disease (34)
IgA nephropathy (73)
Immunology and inflammation (177)
Immuno-oncology (44)
Indications (96)
Infectious disease (2106)
Inflammatory bowel disease (142)
Inflation Reduction Act (12)
Influenza (92)
Intellectual property (188)
Interviews (279)
IPO (9563)
IRA (30)
Job creations (2237)
Job search strategy (1125)
JPM (47)
Kidney cancer (10)
Labor market (51)
Layoffs (278)
Leadership (29)
Legal (5071)
Liver cancer (61)
Longevity (10)
Lung cancer (562)
Lymphoma (307)
Machine learning (28)
Management (33)
Manufacturing (606)
MASH (131)
Medical device (8222)
Medtech (8257)
Mergers & acquisitions (12096)
Metabolic disorders (924)
Multiple sclerosis (131)
NASH (11)
Neurodegenerative disease (241)
Neuropsychiatric disorders (56)
Neuroscience (2153)
NextGen: Class of 2026 (4005)
Non-profit (3134)
Now hiring (27)
Obesity (398)
Opinion (206)
Ovarian cancer (111)
Pain (147)
Pancreatic cancer (165)
Parkinson's disease (215)
Partnered (24)
Patents (351)
Patient recruitment (350)
Peanut (41)
People (35840)
Pharmaceutical (18)
Pharmacy benefit managers (17)
Phase 1 (13484)
Phase 2 (18791)
Phase 3 (15437)
Pipeline (4536)
Policy (166)
Postmarket research (1869)
Preclinical (6022)
Press Release (49)
Prostate cancer (220)
Psychedelics (28)
Radiopharmaceuticals (189)
Rare diseases (649)
Real estate (3850)
Recruiting (40)
Regulatory (16174)
Reports (30)
Research institute (1774)
Resumes & cover letters (235)
Rett syndrome (27)
RNA editing (10)
RSV (51)
Schizophrenia (109)
Series A (191)
Series B (141)
Service/supplier (4)
Sickle cell disease (79)
Special edition (13)
Spinal muscular atrophy (116)
Sponsored (32)
Startups (1962)
State (2)
Stomach cancer (12)
Supply chain (75)
Tariffs (41)
The Weekly (75)
Vaccines (696)
Venture capital (53)
Weight loss (243)
Women's health (66)
Worklife (14)
Date
Today (36)
Last 7 days (486)
Last 30 days (1633)
Last 365 days (23874)
2026 (2695)
2025 (24067)
2024 (24392)
2023 (26051)
2022 (33923)
2021 (35938)
2020 (35325)
2019 (29850)
2018 (22307)
2017 (21410)
2016 (20915)
2015 (23903)
2014 (19709)
2013 (17108)
2012 (17280)
2011 (16983)
2010 (15770)
Location
Africa (624)
Alabama (68)
Alaska (5)
Arizona (157)
Arkansas (10)
Asia (26903)
Australia (4432)
California (8581)
Canada (2474)
China (857)
Colorado (390)
Connecticut (414)
Delaware (281)
Europe (63274)
Florida (1256)
Georgia (252)
Hawaii (3)
Idaho (41)
Illinois (677)
India (55)
Indiana (408)
Iowa (14)
Japan (371)
Kansas (84)
Kentucky (22)
Louisiana (14)
Maine (46)
Maryland (985)
Massachusetts (6300)
Michigan (244)
Minnesota (393)
Mississippi (2)
Missouri (111)
Montana (19)
Nebraska (13)
Nevada (105)
New Hampshire (46)
New Jersey (2494)
New Mexico (19)
New York (2322)
North Carolina (1092)
North Dakota (6)
Northern California (4134)
Ohio (250)
Oklahoma (16)
Oregon (22)
Pennsylvania (1660)
Puerto Rico (9)
Rhode Island (39)
South America (876)
South Carolina (34)
Southern California (3410)
Tennessee (152)
Texas (1360)
United States (30644)
Utah (262)
Vermont (1)
Virginia (201)
Washington D.C. (61)
Washington State (713)
West Virginia (3)
Wisconsin (111)
Wyoming (2)
459,189 Results for "g and w laboratories".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Ocular Therapeutix™ Appoints David W. Robinson as Global Chief Commercial Officer
January 21, 2026
·
10 min read
Press Releases
NeuroEM Therapeutics(R) Appoints Dr. W. Scott Burgin as Chief Medical Officer
February 1, 2026
·
2 min read
Press Releases
Eikon Therapeutics Announces the Election of David W. Meline to its Board of Directors
December 3, 2025
·
2 min read
Press Releases
ViroMissile Appoints Michael G. Wood as Chief Business Officer
January 16, 2026
·
3 min read
Press Releases
Charles River Laboratories Schedules Fourth-Quarter 2025 Earnings and 2026 Guidance Release and Conference Call
January 22, 2026
·
1 min read
Obesity
Protagonist Enters Obesity Fray With Triple-G Pill, Eyeing 2026 Clinical Start
With PN-477, Protagonist is directly going up against Eli Lilly, which is advancing retatrutide, also a triple-G agonist, in a Phase II trial.
July 1, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Emergent BioSolutions Announces Retirement of Dr. Louis W. Sullivan from Board of Directors
November 13, 2025
·
1 min read
Press Releases
Soleno Therapeutics Announces the Passing of Board Member William G. Harris
December 4, 2025
·
3 min read
Press Releases
Charles River Laboratories Provides Business Updates
January 13, 2026
·
14 min read
Press Releases
Revolution Medicines Doses First Patient in Clinical Trial Evaluating RMC-5127, a RAS(ON) G12V-Selective Inhibitor
January 29, 2026
·
4 min read
1 of 45,919
Next
